基于指南与限制性液体复苏策略在合并心力衰竭的脓毒症患者中的应用:系统评价与Meta分析
该系统评价与Meta分析于2023年3月7日检索Embase、PubMed和Scopus,纳入2016年以来发表的4项研究,比较合并心力衰竭的脓毒症患者中,遵循指南的液体复苏策略(3小时内至少30 mL/kg静脉晶体液)与限制性策略(3小时内<30 mL/kg)对院内死亡率的影响。结果显示,未达到30×3目标组院内死亡风险显著高于达标组(OR=1.81,95%CI=1.13-2.89,P=0.01)。作者结论认为限制性液体复苏增加合并心力衰竭脓毒症患者的院内死亡风险,但确定该人群最佳液体复苏策略仍需更严谨的研究。
要点
- 合并心力衰竭的脓毒症患者,3小时内液体量<30 mL/kg者院内死亡风险显著高于达到≥30 mL/kg者(OR=1.81,95%CI=1.13-2.89,P=0.01)。
- 检索于2023年3月7日进行,共获26,069条记录,最终纳入4项研究,均为2016年以来发表、含合并心力衰竭脓毒症患者院内死亡率按30×3目标分层数据的英文文献。
- 作者结论:限制性液体复苏增加合并心力衰竭脓毒症患者的院内死亡风险。
- 作者指出,确定该人群最佳液体复苏策略仍需更严谨的研究。
适用人群与场景
- 合并心力衰竭病史的脓毒症患者,纳入研究需提供这些患者是否在3小时内达到30 mL/kg液体目标的院内死亡率数据。
- 排除:重复研究、关注时间窗宽于脓毒症诊断后3小时的研究、未按心力衰竭患者分层报告死亡率的研究、标题/摘要无关的研究、未经IRB批准的研究;语言限英文。
诊断标准与关键阈值
- 指南-based策略:3小时内至少30 mL/kg静脉晶体液(30×3目标)。
- 限制性策略:3小时内<30 mL/kg静脉晶体液。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,遵循PRISMA指南,检索Embase、PubMed和Scopus(2023年3月7日),最终纳入4项研究,效应量为OR。
- 主要结果:与达到30×3目标组相比,<30×3组院内死亡风险显著更高(OR=1.81,95%CI=1.13-2.89,P=0.01)。
- 异质性以I²统计量评估;发表偏倚采用Egger线性回归及Berg和Mazumdar秩相关评估,并用漏斗图可视化。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(纳入4项研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在合并心力衰竭的脓毒症患者中,限制性液体复苏(3小时内<30 mL/kg)与院内死亡风险升高相关(OR=1.81,95%CI=1.13-2.89,P=0.01)。
- 作者指出,确定该人群最佳液体复苏策略仍需更严谨的研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine whether a fluid resuscitation strategy based on guidelines (at least 30 mL/kg IV crystalloids) vs. a restrictive approach with <30 mL/kg within three hours affects in-hospital mortality in patients with sepsis and a history of heart failure (HF).
DATA SOURCES: On 03/07/2023, we searched Embase, PubMed, and Scopus for peer-reviewed papers and abstracts using the PRISMA guidelines.
STUDY SELECTION: The language was limited to English. Studies published since 2016 included if they had sepsis patients with a history of HF, or a subgroup of patients with HF, and in-hospital mortality data on these patients that did or did not meet the 30 mL/kg by 3 h (30 × 3) goal. Duplicate studies, studies that focused on a broader period than 3 h from the diagnosis of sepsis or without mortality breakdown for HF patients or with unrelated title/abstract, or without an IRB approval were excluded.
DATA EXTRACTION: In-hospital mortality data was taken from the final studies for HF patients with sepsis who did or did not meet the 30 × 3 goal.
DATA SYNTHESIS: The meta-analysis was performed using the Review Manager 5.4 program with ORs as the effect measure. The ProMeta program version 3.0 was used to evaluate the publication bias. Egger's linear regression and Berg and Mazumdar's rank correlation was used to evaluate the publication bias. The result was visually represented by a funnel plot. To estimate the proportion of variance attributable to heterogeneity, the I2 statistic was calculated.
RESULTS: The search yielded 26,069 records, which were narrowed down to 4 studies. Compared to those who met the 30 × 3 goal, the <30 × 3 group had a significantly higher risk of in-hospital mortality (OR = 1.81, 95% CI = 1.13-2.89, P = 0.01).
CONCLUSIONS: Restrictive fluid resuscitation increased the risk of in-hospital mortality in HF patients with sepsis. More rigorous research is required to determine the optimal fluid resuscitation strategy for this population.
参考来源
- Vaeli Zadeh A, Wong A, Crawford AC, et al. Guideline-based and restricted fluid resuscitation strategy in sepsis patients with heart failure: A systematic review and meta-analysis. Am J Emerg Med. 2023. PMID: 37597449. doi:10.1016/j.ajem.2023.08.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。